Contact
searchSearch
HMP Global
Login

June 2021

Featured Article

Research Reports
US Value-Based Management of Oncology Drugs: An Explorative Study of Payer and Provider Tools to Manage the Rising Spending on Oncology Drugs
06/21/2021
Anne Runyan, BA , and colleagues point out that, despite increasing cancer costs in the United States, payers’ willingness and ability to manage oncology drugs remains limited.
Anne Runyan, BA , and colleagues point out that, despite increasing cancer costs in the United States, payers’ willingness and ability to manage oncology drugs remains limited.
Anne Runyan, BA , and colleagues...
06/21/2021
Journal of Clinical Pathways

Column

Trending From ACCC
An Optimal Care Coordination Model for Medicaid Patients With Lung Cancer
06/22/2021
J Clin Pathways. 2021;7(5):24-25. In 2016, the Association of Community Cancer Centers (ACCC) embarked on a 3-year, multiphase initiative to design, test, and refine an Optimal Care Coordination Model (the Model) for Medicaid patients...
J Clin Pathways. 2021;7(5):24-25. In 2016, the Association of Community Cancer Centers (ACCC) embarked on a 3-year, multiphase initiative to design, test, and refine an Optimal Care Coordination Model (the Model) for Medicaid patients...
J Clin Pathways....
06/22/2021
Journal of Clinical Pathways
COA Viewpoint
Keeping Up With the Latest in Health Policy
06/22/2021
Mark Thompson, MD, discusses drug pricing reform under the Biden administration.
Mark Thompson, MD, discusses drug pricing reform under the Biden administration.
Mark Thompson, MD, discusses...
06/22/2021
Journal of Clinical Pathways
Editor's Page
Progress in Value-Based Reimbursement
06/22/2021
Winston Wong, PharmD, discusses the articles in this issue, which include research on new payment models and payer management tools, and results from a study on the effectiveness of eribulin in subgroups of metastatic breast cancer patients...
Winston Wong, PharmD, discusses the articles in this issue, which include research on new payment models and payer management tools, and results from a study on the effectiveness of eribulin in subgroups of metastatic breast cancer patients...
Winston Wong, PharmD, discusses...
06/22/2021
Journal of Clinical Pathways
Pharma Insights
Value Transformation: Observations on Performance Periods 1-5 Evaluation Report of the Oncology Care Model
06/21/2021
Maureen Hennessey, PhD, CPCC, CPHQ, discusses Medicare spending as well as other performance measures related to the patient experience, management of depression and pain, emergency department and hospital use, end-of-life care, and...
Maureen Hennessey, PhD, CPCC, CPHQ, discusses Medicare spending as well as other performance measures related to the patient experience, management of depression and pain, emergency department and hospital use, end-of-life care, and...
Maureen Hennessey, PhD, CPCC,...
06/21/2021
Journal of Clinical Pathways

Department

Research in Review
Research in Review
06/21/2021
JCP Editors
J Clin Pathways. 2021;7(5):16-17. Real-World Health Care Utilization and Costs in the Huntsman at Home Program A recent study found that an oncology hospital at home program model may lower unplanned health care utilization and health...
J Clin Pathways. 2021;7(5):16-17. Real-World Health Care Utilization and Costs in the Huntsman at Home Program A recent study found that an oncology hospital at home program model may lower unplanned health care utilization and health...
J Clin Pathways....
06/21/2021
Journal of Clinical Pathways

Feature

Research Reports
Effectiveness of Eribulin in Metastatic Breast Cancer Patients With Poor Prognostic Indicators in the United States
06/21/2021
A retrospective real-world study demonstrates the clinical effectiveness of eribulin in subgroups of MBC patients with poor prognostic characteristics, when used in accordance with the approved US indication.
A retrospective real-world study demonstrates the clinical effectiveness of eribulin in subgroups of MBC patients with poor prognostic characteristics, when used in accordance with the approved US indication.
A retrospective real-world study...
06/21/2021
Journal of Clinical Pathways
JCP September/October 2024 Issue

Current Issue

October 2024
Volume 10
Issue 5
Current Issue
Issue Archive

Special Reports

JCP Special Report
Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group
05/20/2022
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways...
05/20/2022
Journal of Clinical Pathways

Subscribe

Journal of Clinical Pathways Newsletter

June 2021 Volume 7 Issue 5

View Issue Archive
Editorial Correspondence

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use